NCT00772759View on ClinicalTrials.gov

Assess Safety, Tolerability and PK of AZD3199 in Japanese

PHASE1CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

October 31, 2008

Study Completion Date

February 28, 2009

Conditions

Healthy

Interventions

DRUG

AZD3199 Turbuhaler®

240, 720 and 2160 μ g, single and multiple (o.d. for 12 days)

DRUG

Placebo Turbuhaler®

single and multiple (o.d. for 12 days)

Trial Locations (1)

Unknown

Research Site, Slough

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY